Vedanta Biosciences, Inc.

Vedanta Biosciences, Inc. is a biopharmaceutical company based in the United States, with approximately 51 employees. The company is pioneering the development of rational, defined bacterial consortia therapies to treat gastrointestinal diseases through microbiome modulation. Vedanta has a robust product pipeline and extensive intellectual property portfolio, and is at the forefront of transformative science in the microbiome field.